Sugi Predict
/ Targets
/ UGP2
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours |
|---|
Clinical trials — most relevant to UGP2 by text similarity (a relevance ranking, not an exhaustive list)
| Trial | Phase | Status |
|---|
| Pharmacokinetics and Pharmacogenetics-based Adaptive Dosing of 5-fu (5-Fluorouracile) in Head & Neck Cancer Patient Undergoing Docetaxel, Cisplatin, 5-Fluorouracile (=TPF) Therapy |
PHASE4 | COMPLETED |
| The Intervention of Multi-vitamin With Minerals to Hyperuricemia |
PHASE4 | UNKNOWN |
| SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2 |
PHASE3 | COMPLETED |
| University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial |
PHASE1/PHASE2 | COMPLETED |
| A Phase I/II Open-label Safety and Efficacy Study of LNP.UCD.ABE in Patients With Urea Cycle Disorders. |
PHASE1/PHASE2 | NOT_YET_RECRUITING |
| Vaccine Treatment for Advanced Non-Small Cell Lung Cancer |
PHASE1/PHASE2 | COMPLETED |
| Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma |
PHASE1/PHASE2 | COMPLETED |
| Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors |
PHASE1 | COMPLETED |
| Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer |
PHASE1 | COMPLETED |
| SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia |
PHASE1 | RECRUITING |
| Glycosylation in Patients With Galactosaemia |
nan | COMPLETED |
| Epidemiology of Gout in French Polynesia |
nan | COMPLETED |
| Dose-response Effect of Alcohol Ingestion on Steroid Profile |
nan | COMPLETED |
| Purine Metabolism Enzyme SNP to Uric Acid Production |
nan | COMPLETED |
| Genetic-specific Effects of Fructose on Liver Lipogenesis |
nan | COMPLETED |
| Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia |
nan | NOT_YET_RECRUITING |
| Genetics and Epidemiology of Aging Associated Conditions in the Sardinian Population |
nan | COMPLETED |
| Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic Factors |
nan | COMPLETED |
| Dried Fruit and Postprandial Glycemia Trial |
nan | UNKNOWN |
| Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network |
nan | RECRUITING |
| Liver Disease in Urea Cycle Disorders |
nan | ACTIVE_NOT_RECRUITING |
| EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND) |
nan | RECRUITING |
| A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders |
nan | RECRUITING |
| Chronic Liver Disease in Urea Cycle Disorders |
nan | COMPLETED |
| Neurologic Injuries in Adults With Urea Cycle Disorders |
nan | COMPLETED |
| Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis |
nan | UNKNOWN |
| Application of UCPCR as a Testing Tool for Identification of MODY Patients in the UAE |
nan | UNKNOWN |
| Uric Acid Based Renal Stones: Clinical, Metabolic and Genetic Characterization |
nan | UNKNOWN |
| Genome-Wide Assocation Study in Patients With Brain Injury Associated Fatigue and Altered Cognition (BIAFAC) |
nan | COMPLETED |
| Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer |
nan | WITHDRAWN |
Related proteins — ESM-2 sequence neighbours (a UGP2 binder may also engage these)